IL291174B2 - Process for the preparation of a medicament containing an oxepane ring. - Google Patents

Process for the preparation of a medicament containing an oxepane ring.

Info

Publication number
IL291174B2
IL291174B2 IL291174A IL29117422A IL291174B2 IL 291174 B2 IL291174 B2 IL 291174B2 IL 291174 A IL291174 A IL 291174A IL 29117422 A IL29117422 A IL 29117422A IL 291174 B2 IL291174 B2 IL 291174B2
Authority
IL
Israel
Prior art keywords
preparation
medicament containing
oxepane ring
oxepane
ring
Prior art date
Application number
IL291174A
Other languages
Hebrew (he)
Other versions
IL291174A (en
IL291174B1 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL291174A publication Critical patent/IL291174A/en
Publication of IL291174B1 publication Critical patent/IL291174B1/en
Publication of IL291174B2 publication Critical patent/IL291174B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL291174A 2019-09-11 2020-09-10 Process for the preparation of a medicament containing an oxepane ring. IL291174B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962898861P 2019-09-11 2019-09-11
US201962934382P 2019-11-12 2019-11-12
PCT/US2020/050086 WO2021050654A1 (en) 2019-09-11 2020-09-10 Process for the preparation of a medicament containing an oxepane ring.

Publications (3)

Publication Number Publication Date
IL291174A IL291174A (en) 2022-05-01
IL291174B1 IL291174B1 (en) 2024-12-01
IL291174B2 true IL291174B2 (en) 2025-04-01

Family

ID=72614037

Family Applications (1)

Application Number Title Priority Date Filing Date
IL291174A IL291174B2 (en) 2019-09-11 2020-09-10 Process for the preparation of a medicament containing an oxepane ring.

Country Status (20)

Country Link
US (1) US11414412B2 (en)
EP (1) EP4028396B1 (en)
JP (1) JP7370457B2 (en)
KR (1) KR102786186B1 (en)
CN (1) CN114341134B (en)
AU (1) AU2020345916B2 (en)
BR (1) BR112022004455B1 (en)
CA (1) CA3147844A1 (en)
CL (1) CL2022000581A1 (en)
CR (1) CR20220100A (en)
ES (1) ES2972049T3 (en)
IL (1) IL291174B2 (en)
MX (1) MX2022002962A (en)
MY (1) MY208408A (en)
PE (1) PE20220709A1 (en)
PL (1) PL4028396T3 (en)
SA (1) SA522431923B1 (en)
TW (1) TWI856177B (en)
WO (1) WO2021050654A1 (en)
ZA (1) ZA202202178B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130296569A1 (en) * 2010-11-03 2013-11-07 Vijaykumar Jagdishwar Patil Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
WO2014048939A1 (en) 2012-09-26 2014-04-03 F. Hoffmann-La Roche Ag Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
MX2016012007A (en) * 2014-03-18 2016-12-05 Hoffmann La Roche Oxepan-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use.
SE540295C2 (en) * 2016-12-05 2018-05-29 Glactone Pharma Dev Ab Sulfonamide analogues of galiellalactone

Also Published As

Publication number Publication date
TWI856177B (en) 2024-09-21
SA522431923B1 (en) 2024-04-15
CN114341134B (en) 2024-03-08
ES2972049T3 (en) 2024-06-10
EP4028396A1 (en) 2022-07-20
CN114341134A (en) 2022-04-12
JP7370457B2 (en) 2023-10-27
EP4028396B1 (en) 2024-01-03
AU2020345916B2 (en) 2026-08-13
US11414412B2 (en) 2022-08-16
PL4028396T3 (en) 2024-04-29
JP2022547536A (en) 2022-11-14
TW202116309A (en) 2021-05-01
CL2022000581A1 (en) 2022-10-07
CR20220100A (en) 2022-05-23
US20210070749A1 (en) 2021-03-11
BR112022004455B1 (en) 2024-04-30
BR112022004455A2 (en) 2022-06-14
KR102786186B1 (en) 2025-03-27
IL291174A (en) 2022-05-01
EP4028396C0 (en) 2024-01-03
CA3147844A1 (en) 2021-03-18
MX2022002962A (en) 2022-09-29
PE20220709A1 (en) 2022-05-04
WO2021050654A1 (en) 2021-03-18
IL291174B1 (en) 2024-12-01
MY208408A (en) 2025-05-08
AU2020345916A1 (en) 2022-03-03
ZA202202178B (en) 2024-06-26
KR20220047324A (en) 2022-04-15

Similar Documents

Publication Publication Date Title
ZA202102696B (en) Anti-b7h3 antibody-exatecan analog conjugate and medicinal use thereof
GB201903767D0 (en) Multimers, tetramers & octamers
EP4349406A3 (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole for use as a medicament
WO2016079751A3 (en) A process for preparation of vortioxetine and polymorphs thereof
PL3736228T3 (en) Capsule for preparing a beverage, method of producing the same and use of the capsule
CA190818S (en) Ring
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
GB2593352B (en) Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone)
IL289904B1 (en) Process for the preparation of biphenylamines
ZA202006907B (en) A fatty preparation, a process for making said fatty preparation, and a product containing the same
WO2016055647A3 (en) Method for preparing universal plasma
IL283633A (en) Process for the preparation of a cyclic dinucleotide
IL286743A (en) Capsule for infusion products
PL4037679T3 (en) A process for the preparation of highly pure valsartan
IL291174A (en) Process for the preparation of a medicament containing an oxepane ring.
IL286054A (en) Process for the preparation of a substituted imidazoquinoline
ZA202102159B (en) Process for the preparation of a flavouring
PL3774752T3 (en) Process for the preparation of glycidol
PL3725774T3 (en) Process for the preparation of a pharmaceutical agent
EP3902982A4 (en) A nozzle ring structure
EP3273967A4 (en) A process for the preparation of lorcaserin hydrochloride
ZA202006906B (en) A fatty preparation, a process for making said fatty preparation, and a product containing the same
IL288972A (en) Continuous process for the preparation of anticholinergic drugs
HK40063705A (en) Medicament container
EP4013502B8 (en) Process for the preparation of a pyrimidino-diazepine derivative